Cellectar Biosciences, Inc. (CLRB) › Shareholders' EquityCellectar Biosciences, Inc. (CLRB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2002: $599.4K2003: $388.9K2004: $46.2K2005: $400.2K2006: $6.55M2007: $2.53M2008: $9.84M2009: $4.13M2010: $133.8K2011: $9.48M2012: $10.16M2013: $1.70M2014: $6.70M2015: $1.65M2016: $13.54M2017: $10.75M2018: $13.26M2019: $9.06M2020: $54.79M2021: $29.06M2022: $8.15M2023: -$15.16M2024: $14.29M2025: $8.54M$8.54M2002Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$8.54M-40.3%2024$14.29M+194.3%2023-$15.16M-285.9%2022$8.15M-71.9%2021$29.06M-47.0%2020$54.79M+504.8%2019$9.06M-31.7%2018$13.26M+23.3%2017$10.75M-20.6%2016$13.54M+720.7%2015$1.65M-75.4%2014$6.70M+294.1%2013$1.70M-83.3%2012$10.16M+7.1%2011$9.48M+6988.1%2010$133.8K-96.8%2009$4.13M-58.1%2008$9.84M+289.7%2007$2.53M-61.4%2006$6.55M+1535.7%2005$400.2K+766.7%2004$46.2K-88.1%2003$388.9K-35.1%2002$599.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share